Phase III Randomized, Double-Blind Study of Potassium Phosphate Vs Potassium Citrate for Absorptive Hypercalciuria
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
OBJECTIVES: I. Evaluate the ability of a slow-releasing formulation of neutral potassium
phosphate to correct hypercalciuria and prevent recurrent stone formation in patients with
absorptive hypercalciuria.
II. Evaluate the safety of this treatment. III. Compare the efficacy of potassium phosphate
to that of potassium citrate.
Phase:
Phase 3
Details
Lead Sponsor:
National Center for Research Resources (NCRR)
Collaborators:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) University of Texas